| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.008 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |